Incyte Corporation, a Delaware-based biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

- New facility to serve as European base for Incyte’s drug development operations

- Location provides efficient access to key clinical trial experts and institutions
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2034738
Find an actor

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

BioAlps World Visibitlity Package 2019

A yearly international programme for our affiliated companies to increase their visibility.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn